Literature DB >> 21816048

Rare recurrence of a rare ovarian stromal tumor with luteinized cells: a case report.

Tazi El Mehdi1, Ismail Essadi, Hind M'rabti, Hassan Errihani.   

Abstract

INTRODUCTION: Sex cord-stromal tumors of the ovary are uncommon. They behave unpredictably and often have a late recurrence, making counseling, management, and prediction of prognosis challenging. CASE
PRESENTATION: A 52-year-old Moroccan woman with an sex cord-stromal tumors underwent a bilateral oophorectomy. The histology was unusual but was likely to be a luteinized thecoma with suspicious features for invasion. Seven years later, after a gastrointestinal bleed, a metastasis within the small bowel mucosa was detected. This represents probable isolated hematogenous or lymphatic spread, which is highly unusual, especially in the absence of concurrent peritoneal disease.
CONCLUSIONS: To the best of our knowledge, this is the second reported case of an sex cord-stromal tumors recurring in small bowel mucosa and mimicking a primary colorectal tumor. This highlights the diverse nature and behavior of these tumors.

Entities:  

Year:  2011        PMID: 21816048      PMCID: PMC3163610          DOI: 10.1186/1752-1947-5-350

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  9 in total

1.  A stromal Leydig cell tumor of the ovary occurring in a pregnant 15-year-old girl. Ultrastructural findings.

Authors:  M Paoletti; G Pridjian; T Okagaki; A Talerman
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

2.  Analysis of autopsy evaluations of ovarian cancer patients treated at the National Cancer Institute, 1972-1988.

Authors:  E Reed; C S Zerbe; O W Brawley; A Bicher; S M Steinberg
Journal:  Am J Clin Oncol       Date:  2000-04       Impact factor: 2.339

Review 3.  Stromal Leydig cell tumor of the ovary. Case report and literature review.

Authors:  S Takeuchi; N Ishihara; C Ohbayashi; H Itoh; T Maruo
Journal:  Int J Gynecol Pathol       Date:  1999-04       Impact factor: 2.762

4.  The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.

Authors:  Jubilee Brown; Hyun S Shvartsman; Michael T Deavers; Lois M Ramondetta; Thomas W Burke; Mark F Munsell; David M Gershenson
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

5.  Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.

Authors:  John K Chan; Mallory Zhang; Vanessa Kaleb; Vera Loizzi; Jacqueline Benjamin; Steve Vasilev; Kathryn Osann; Philip J Disaia
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

6.  Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study.

Authors:  H D Homesley; B N Bundy; J A Hurteau; L M Roth
Journal:  Gynecol Oncol       Date:  1999-02       Impact factor: 5.482

7.  Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection.

Authors:  K A O'Hanlan; S Kargas; M Schreiber; D Burrs; P Mallipeddi; T Longacre; M Hendrickson
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

8.  Metastatic patterns in histologic variants of ovarian cancer. An autopsy study.

Authors:  P G Rose; M S Piver; Y Tsukada; T S Lau
Journal:  Cancer       Date:  1989-10-01       Impact factor: 6.860

9.  Ovarian stromal tumors containing lutein or Leydig cells (luteinized thecomas and stromal Leydig cell tumors)--a clinicopathological analysis of fifty cases.

Authors:  J Zhang; R H Young; J Arseneau; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1982       Impact factor: 2.762

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.